VEGFA and age-related macular degeneration: Injections with anti-vascular endothelial growth factor (anti-VEGF) have become the most common intraocular procedure worldwide due to its considerable effect on several retinal diseases such as age-related macular degeneration (AMD), retinal vein occlusion (RVO) and diabetic macular oedema (DMO) [1].